Income Taxes (Details Narrative) - USD ($) $ in Thousands |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2018 |
|
Operating Loss Carryforwards [Line Items] | ||||
Deferred tax assets | $ 40,160 | $ 37,398 | ||
Deferred tax assets valuation allowance | 40,160 | 37,398 | ||
Valuation allowance | 2,800 | |||
Operating loss carryforwards | 151,400 | $ 134,100 | ||
Research and development costs | 1,800 | |||
Accumulated gross amount | $ 10,600 | |||
Operating loss utilization limit | $ 3,700 | |||
Expire date, description | begin to expire after 2036 through 2042 | |||
ISRAEL | ||||
Operating Loss Carryforwards [Line Items] | ||||
Operating loss carryforwards | $ 81,480 | |||
[custom:DeferredForeignIncomeTaxExpenseBenefitAvailableUse] | 37,600 | |||
Federal [Member] | ||||
Operating Loss Carryforwards [Line Items] | ||||
Operating loss carryforwards | 3,300 | $ 32,376 | ||
State and Local Jurisdiction [Member] | ||||
Operating Loss Carryforwards [Line Items] | ||||
Operating loss carryforwards | $ 34,266 |
X | ||||||||||
- Definition Deferred foreign income tax benefit available use. No definition available.
|
X | ||||||||||
- Definition Expire date, description No definition available.
|
X | ||||||||||
- Definition Operating loss carryforwards utilization limitation. No definition available.
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|